Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist

Neuropharmacology

Volumn 36, Issue 1, 1997, Pages 31-37

  Przegalinski E ^a   Tatarczynska E ^a   Deren Wesolek A ^a   Chojnacka Wojcik E ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1 aminocyclopropanecarboxylic acid; CGP 37849; forced swimming test; intrahippocampal injection; peripheral administration; rats

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; ANTIDEPRESSANT AGENT; DIAZEPAM; GLYCINE RECEPTOR; GLYCINE RECEPTOR AGONIST; IMIPRAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FORCED SWIMMING TEST; HIPPOCAMPUS; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

2-AMINO-5-PHOSPHONOVALERATE; AMINO ACIDS; AMINO ACIDS, CYCLIC; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0343052958     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(96)00157-8     Document Type: Article

References (49)

1. Anthony E.W., Nevins M.E. Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test. Eur. J. Pharmacol. 250:1993;317-324.
2. Beardsley P.M., Hayes B.A., Balster R.L. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. J. Pharmacol. Exp. Ther. 252:1990;953-996.
3. Bennett D.A., Bernard P., Amrick C.L., Wilson D., Liebman J., Hutchison A. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 250:1989;454-460.
4. 3H]strychnine binding sites in rat brain. Eur. J. Pharmacol. 126:1986;303-307.
5. Charney D.S., Menkes D.B., Heningen G.R. Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch. Gen. Pharmacol. 38:1981;1160-1180.
6. Eichelman B. The limbic system and aggression in humans. Neurosci. Biobehav. Res. 7:1983;391-394.
7. Fagg G.E., Olpe H.-R., Pozza M.F., Baud J., Steinmann M., Schmutz M., Portet C., Baumann P., Thedinga K., Bittiger H., Allgeier H., Heckendorn R., Angst C., Brundish D., Dingwall J.G. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. Br. J. Pharmacol. 99:1990;791-797.
8. Herberg L.J., Rose I.C. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Psychopharmacology. 99:1989;87-90.
9. Hrdina P.D. Antidepressant binding: implications for the mode of action and the biology of depression. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 7:1983;457-462.
10. Izquierdo I. Role of NMDA receptors in memory. Trends Pharmacol. Sci. 12:1991;128-129.
11. Janssen P.A.J., Jagenau A.H.M., Schellekens K.H.C. Chemistry and pharmacology of compound related to 4-(4-hydroxy-4-phenylpiperidino)-butyrophenone. IV: Influence of haloperidol (R-1625) and chloropromazine on the behaviour of rats in a unfamiliar open field situation Psychopharmacology. 1:1960;389-392.
12. 2 receptors in the chronic mild stress model of depression in rats. Pol. J. Pharmacol. 46:1994;67-69.
13. Koek W., Colpaert F.C. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. J. Pharmacol. Exp. Ther. 252:1990;349-357.
14. Koek W., Woods J.H., Winger G.D. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245:1988;969-974.
15. Kostowski W. Possible relationship of the locus coeruleus-hippocampal noradrenergic neurons to depression and mode of action of antidepressant drugs. Pol. J. Pharmac. Pharmacol. 37:1985;727-743.
16. Layer R.T., Popik P., Olds T., Skolnick P. Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol. Biochem. Behav. 52:1995;621-627.
17. 1A receptors. J. Pharmacol. Exp. Ther. 257:1991;1146-1153.
18. Löscher W., Annies R., Hönack D. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128:1991;191-194.
19. Löscher W., Annies R., Hönack D. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. Eur. J. Pharmacol. 242:1993;263-274.
20. Maj J., Klimek V., Gołembiowska K., Rogóż Z., Skuza G. Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity. Pol. J. Pharmacol. 45:1993;455-466.
21. Maj J., Przegaliński E., Mogilnicka E. Hypotheses concerning the mechanism of action of antidepressant drugs. Rev. Physiol. Biochem. Pharmacol. 100:1984;1-74.
22. Maj J., Rogóż Z., Skuza G., Sowińska H. Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur. Neuropsychopharmacol. 2:1992;37-41.
23. Maj J., Rogóż Z., Skuza G., Sowińska H. The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. Pol. J. Pharmac. Pharmacol. 44:1992;337-346.
24. Maj J., Rogóż Z., Skuza G., Kołodziejczyk K. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7-dichlorokynurenic acid, glycine site antagonist. Pol. J. Pharmacol. 46:1994;115-124.
25. Marvizón J.C.G., Lewin A.H., Skolnick P. 1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex. J. Neurochem. 52:1989;992-994.
26. Miller W.R. Psychological deficit in depression. Psychol. Bull. 82:1975;238-260.
27. Mizuta T., Segawa T. Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus and choroid plexus: quantitative receptor autoradiographic analysis. Japan. J. Pharmacol. 50:1989;315-326.
28. 3H]glutamate binding sites. Nature. 306:1983;176-179.
29. 3H]amino-5-phosphonopentanoate binding sites in rat brain. Neurosci. Lett. 52:1984;253-258.
30. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by a N-methyl-D-aspartate antagonist AP5. Nature. 319:1986;774-776.
31. Nadler V., Kloog Y., Sokolovsky M. 1-Aminocyclopropane-1-carboxylic acid (ACC) mimics the effects of glycine on the NMDA receptor ion channel. Eur. J. Pharmacol. 157:1989;115-116.
32. Newman M.E., Lerer B. Chronic electroconvulsive shock and desipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes. Eur. J. Pharmacol. 148:1988;257-260.
33. Papp M., Moryl E. Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol. 263:1994;1-7.
34. Papp M., Moryl E. Rewarding properties of noncompetitive and competitive NMDA antagonists as measured by place preference conditioning in rats. Pol. J. Pharmacol. 46:1994;79-81.
35. Paul I.A., Trullas R., Skolnick P., Nowak G. Down-regulation of cortical β-adrenoceptors by chronic treatment with functional NMDA antagonists. Psychopharmacology. 106:1992;285-287.
36. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
37. Płaźnik A., Pałejko W., Nazar M., Jessa M. Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur. Neuropsychopharmacol. 4:1994;503-512.
38. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47:1978;379-391.
39. Przegaliński E., Tatarczyńska E., Dereń-Wesołek A., Chojnacka-Wójcik E. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors. Pharmacol. Biochem. Behav. 54:1996;73-77.
40. Sherman A.D., Allers G.L. Relationship between regional distribution of imipramine and its effect on learned helplessness in the rat. Neuropharmacology. 19:1980;159-162.
41. Skolnick P., Miller R., Young A., Boje K., Trullas R. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex. Psychopharmacology. 107:1992;489-496.
42. Trullas R., Folio T., Young A., Miller R., Boje K., Skolnick P. 1-Aminocyclopropanecarboxylates exhibit anti-depressant and anxiolytic actions in animal models. Eur. J. Pharmacol. 203:1991;379-385.
43. Trullas R., Jackson B., Skolnick P. Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors. Pharmacol. Biochem. Behav. 34:1989;313-316.
44. Trullas R., Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol. 185:1990;1-10.
45. Turski L., Klockgether T., Sontag K.H., Herrling P.L., Watkins J.C. Muscle relaxant and anticonvulsant activity of 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist in rodents. Neurosci. Lett. 73:1987;143-148.
46. Watson G.B., Lanthorn T.H. Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site. Neuropharmacology. 29:1990;727-730.
47. Whitton P.S., Biggs C.S., Pearce B.R., Fowler L.J. MK-801 increases extracellular 5-hydroxytryptamine in rats hippocampus and striatum in vivo. J. Neurochem. 58:1992;1573-1575.
48. Willetts J., Balster R.L., Leander J.D. The behavioural pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci. 1:1990;423-428.
49. Winslow J.T., Insel T.R., Trullas R., Skolnick P. Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor complex. Eur. J. Pharmacol. 190:1990;11-21.